{"status": "ok", "totalResults": 186, "articles": [{"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "Pharma stks rise 4%; Aurobindo, Sun in focus", "description": "The Nifty Pharma index was trading 2.43 per cent up at 10,644 around 10:45 am.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/stock-market-update-pharma-stocks-jump-up-to-4-aurobindo-pharma-sun-pharma-hog-limelight/articleshow/65804995.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65805018,width-1070,height-580,imgsize-27371,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-14T05:14:10Z", "content": "NEW DELHI: Most pharma stocks were trading in the positive territory during Friday's session, giving a boost to the sectoral index. The Nifty Pharma index was trading 2.43 per cent up at 10,644 around 10:45 am on Friday with all components in the green. Aurob\u2026 [+1184 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "Buzzing stocks: JPA, Lanco Infra, Axis, RIL,", "description": "Among the 50 stocks in the Nifty index, 25 were in the green and 25 in the red.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/buzzing-stocks-jp-associates-lanco-infratech-axis-bank-ril-bajaj-finance/articleshow/65763736.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65763746,width-1070,height-580,imgsize-117449,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-11T04:20:30Z", "content": "NEW DELHI: With over 1.70 crore shares changing hands, the counter of Jaiprakash Associates was buzzing as the most traded stock on NSE in morning session on Tuesday. Uttam Value Steels (number of shares traded: 1.35 crore), Lanco Infratech (1.26 crore) and R\u2026 [+1202 chars]"}, {"source": {"id": null, "name": "Indianexpress.com"}, "author": "PTI", "title": "Sensex, Nifty turn choppy on mixed Asian cues", "description": "Investors turned cautious as trade war concerns between the US and China rose and a persistent weakness in the rupee became lingering concerns leading to volatility in the market, brokers said.", "url": "https://indianexpress.com/article/business/sensex-nifty-turn-choppy-on-mixed-asian-cues-5350193/", "urlToImage": "https://images.indianexpress.com/2018/07/bse-sensex-759.jpg?w=759", "publishedAt": "2018-09-11T06:46:18Z", "content": "By: PTI | Mumbai | Published: September 11, 2018 12:16:18 pm Top gainers include Axis Bank, Infosys, Adani Ports, Sun Pharma, M&amp;M, SBI and Tata Motors, rising up to 2 per cent. (File photo) The BSE benchmark Sensex Tuesday rose 95 points, but soon turned \u2026 [+1242 chars]"}, {"source": {"id": null, "name": "Nejm.org"}, "author": "Kim Papp, Kenneth Gordon, Diamant Tha\u00e7i, Akimichi Morita, Melinda Gooderham, Peter Foley, Ihab G. Girgis, Sudeep Kundu, Subhashis Banerjee", "title": "Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis", "description": "Original Article from The New England Journal of Medicine \u2014 Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis", "url": "https://www.nejm.org/doi/full/10.1056/NEJMoa1806382", "urlToImage": "https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/0/nejm.ahead-of-print/nejmoa1806382/20180907/images/img_small/nejmoa1806382_f1.jpeg", "publishedAt": "2018-09-12T06:00:02Z", "content": "Supported by Bristol-Myers Squibb. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. Dr. Papp reports receiving grant support, consulting fees, advisory board fees, and fees for serving on a speakers\u2019 burea\u2026 [+4079 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ET Now", "title": "'Buy pharma as a bucket, be stock-specific in auto sector'", "description": "\u201cRemain bullish on some of the consumption-related stocks which have been beaten down.\u201d", "url": "https://economictimes.indiatimes.com/markets/expert-view/buy-pharma-as-a-bucket-be-stock-specific-in-auto-sudip-bandyopadhyay-inditrade-capital/articleshow/65729844.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65729851,width-1070,height-580,imgsize-24478,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-08T06:14:30Z", "content": "The market is not crashing anytime soon. However, it is not going to move up sharply in a hurry either, Sudip Bandyopadhyay, Group Chairman, Inditrade Capital, tells ET Now. Edited excerpts: Do you believe that we can hold our head above the 10,600 mark? What\u2026 [+5456 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "PTI", "title": "Markets stage relief rally on value-buying", "description": "\u200b\u200bThe session was marked by high volatility and stock-specific action.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/markets-stage-relief-rally-on-value-buying-ril-leads-recovery/articleshow/65714921.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65714915,width-1070,height-580,imgsize-155561,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-07T04:20:06Z", "content": "MUMBAI: Markets staged a strong comeback on Thursday after six straight sessions of losses as investors accumulated recently hammered healthcare, energy and power stocks even as the rupee breached the 72 level for the first time. The BSE Sensex rebounded 224.\u2026 [+333 chars]"}, {"source": {"id": null, "name": "Indianexpress.com"}, "author": "PTI", "title": "Sensex drops 200 pts on weak global cues; Nifty below 11,550", "description": "The NSE Nifty index too shed 44.50 points, or 0.38 per cent, at 11,544.60.", "url": "https://indianexpress.com/article/business/market/sensex-drops-200-points-on-weak-global-cues-nifty-below-11550-5348171/", "urlToImage": "https://images.indianexpress.com/2018/03/sensex-759.jpg?w=759", "publishedAt": "2018-09-10T05:23:30Z", "content": "By: PTI | Mumbai | Updated: September 10, 2018 10:54:59 am The BSE 30-share barometer fell by 206.85 points, or 0.54 per cent, to 38,182.97 in early trade. The BSE benchmark Sensex dropped 200 points in early deals Monday on negative global cues, widening cur\u2026 [+1875 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Sun Pharma gets USFDA nod for specialty eye drug Xelpros", "description": "Sun Pharma management earlier indicated that the peak sales guidance of Xeplros is expected to be in the range of $50-$75 million over two to three years.", "url": "https://www.moneycontrol.com/news/business/companies/sun-pharma-gets-usfda-nod-for-specialty-eye-drug-xelpros-2949461.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/08/Sun-Pharma-770x433.jpg", "publishedAt": "2018-09-14T03:21:41Z", "content": "Moneycontrol News Sun Pharma, India's largest drug maker on Friday said it got an approval from USFDA for its specialty opthalmic drug Xelpros, which is used to treat chronic eye disease glaucoma. The New Drug Application (NDA) of Xelpros was filed from the H\u2026 [+1860 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Stocks in the news: Sun Pharma, JP Associates, Jai Corp, Essel Propack, Manali Petro", "description": "Sun Pharma | JP Associates | Jai Corp | Essel Propack and Manali Petro are stocks, which are in news today.", "url": "https://www.moneycontrol.com/news/business/stocks/stocks-in-the-news-sun-pharma-jp-associates-jai-corp-essel-propack-manali-petro-2939121.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/02/stocks_markets-770x433.jpg", "publishedAt": "2018-09-11T02:12:29Z", "content": "Here are the stocks that are in news today: Ex-Bonus - GlaxoSmithKline Pharmaceuticals - 1:1 Reliance Home Finance : Q1 profit rises to Rs 48 crore versus Rs 34 crore; revenue increases to Rs 404 crore from Rs 383 crore (YoY). Sun Pharma : One of the wholly o\u2026 [+2199 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Stocks in the news: Cipla, Wipro, RIL, Sun Pharma, Alembic, Reliance Capital, Redington", "description": "Cipla | Wipro | Sun Pharma | Syngene International | Reliance Capital and Redington are stocks, which are in news today.", "url": "https://www.moneycontrol.com/news/business/stocks/stocks-in-the-news-cipla-wipro-ril-sun-pharma-alembic-reliance-capital-redington-2943471.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2017/08/sensex_NSE_BSE_Stocks_Stock_market_bse1-770x433.jpg", "publishedAt": "2018-09-12T02:33:05Z", "content": "Here are the stocks that are in news today: Sun Pharma : In its clarification note related to Mohali plant, company said the US FDA is conducting an inspection of Mohali facility (Punjab, India). The inspection started on September 10 and is ongoing. Syngene \u2026 [+4819 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "D-Street Buzz: Aurobindo Pharma, Sun Pharma most active; Motherson Sumi gains 4% on bonus issue", "description": "Metal index extend its gains in the afternoon trade, Coal India, JSW Steel, Vedanta, Tata Steel and Hindalco are among major metal gainers.", "url": "https://www.moneycontrol.com/news/business/markets/d-street-buzz-aurobindo-pharma-sun-pharma-most-active-motherson-sumi-gains-4-on-bonus-issue-2928541.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/07/indian_markets-770x433.jpg", "publishedAt": "2018-09-07T09:11:30Z", "content": "The Indian benchmark indices are witnessing rangebound session on Friday with the Nifty50 trading at 11,573, up 36 points, while the Sensex is trading higher by 81 points at 38,324. Reliance Industries, M&amp;M, ICICI Bank, HUL and Tata Motors are the positiv\u2026 [+1149 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "D-Street Buzz: Nifty pharma underperforms as Sun Pharma down 4%; Infosys up 1%", "description": "Nifty auto gained nearly 1 percent led by Bajaj Auto and TVS Motor up over 3 percent, followed by Apollo Tyres, Ashok Leyland, Exide, M&M and Hero Motocorp.", "url": "https://www.moneycontrol.com/news/business/markets/d-street-buzz-nifty-pharma-underperforms-as-sun-pharma-down-4-infosys-up-1-2927541.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/04/RTR2PMUA-770x433.jpg", "publishedAt": "2018-09-07T04:43:29Z", "content": "The Indian benchmark indices are trading lower on Friday morning with the Nifty50 trading at 11,518, down 18 points, while the Sensex is trading lower by 67 points at 38,175. Nifty pharma is down over 1 percent led by Sun Pharma down 4 percent on buzz of obse\u2026 [+1374 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Sun Pharma arm to acquire shares of Israeli firm Tarsius Pharma for $3 million", "description": "\"Cost of acquisition is $3 million,\" it added. Indicative time period for completion of the acquisition is before September 15, 2018, Sun Pharma said.", "url": "https://www.moneycontrol.com/news/business/sun-pharma-arm-to-acquire-shares-of-israeli-firm-tarsius-pharma-for-3-million-2937571.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/06/Picture-9-770x433.jpg", "publishedAt": "2018-09-10T11:22:05Z", "content": "Drug major Sun Pharmaceutical Industries Monday said it has agreed to acquire 18.75 percent shares of Israel-based Tarsius Pharma for a cash consideration of $3 million (over Rs 21 crore). One of the company's wholly-owned subsidiaries has agreed to acquire 3\u2026 [+503 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Buy Sun Pharma; target of Rs 790: Motilal Oswal", "description": "Motilal Oswal is bullish on Sun Pharma has recommended Buy rating on the stock with a target price of Rs 790 in its research report dated September 07, 2018.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-sun-pharma-target-of-rs-790-motilal-oswal-2936591.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2017/03/buySell4-770x433.jpg", "publishedAt": "2018-09-10T08:46:45Z", "content": "Motilal Oswal 's research report on Sun Pharma US FDA recently conducted an inspection at SUNP's Halol plant from 27-31 August and issued Form-483 with six observations. We believe the observations are resolvable and should not impact existing business and/or\u2026 [+1097 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Credit Suisse maintains #39;outperform#39; rating on Sun Pharma", "description": "The observations made by the US FDA at the firm#39;s Halol plant in Gujarat are not very critical, Credit Suisse added.", "url": "https://www.moneycontrol.com/news/business/markets/credit-suisse-maintains-outperform-rating-on-sun-pharma-2944361.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/08/Sun-Pharma-770x433.jpg", "publishedAt": "2018-09-12T06:53:54Z", "content": "Moneycontrol News Credit Suisse has maintained an \"outperform\" rating on Sun Pharmaceutical Industries with a target price of Rs 705. Credit Suisse added that it sees a potential upside of 12 percent for the stock. The observations made by the US Food and Dru\u2026 [+605 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Sun Pharma, SPARC gain 3-7% on USFDA approval for Xelpros", "description": "This approval is from Sun Pharma\u00e2\u0080\u0099s Halol (Gujarat, India) facility.", "url": "https://www.moneycontrol.com/news/business/markets/sun-pharma-sparc-gain-2-4-on-usfda-approval-for-xelpros-2949451.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/03/SunPharma-770x433.jpg", "publishedAt": "2018-09-14T03:59:24Z", "content": "Shares of Sun Pharmaceutical Industries and Sun Pharma Advanced Research Company gained 3-7 percent in the opening trade on Friday on the back of USFDA approval for Xelpros which is used to treat open-angle Glaucoma or Ocular Hypertension. The company announc\u2026 [+1294 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Aurobindo Pharma, Lupin, Cadila Healthcare, Wockhardt to get astrological support: Satish Gupta", "description": "Pharma stocks like Aurobindo Pharma, Lupin, Cadila Healthcare, Wockhardt and Divis Labs will get astrological support, says Satish Gupta of astrostocktips.", "url": "https://www.moneycontrol.com/news/business/markets/aurobindo-pharma-lupin-cadila-healthcare-wockhardt-to-get-astrological-support-satish-gupta-2950031.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/06/USFDAFDAPILLSDRUGSTABLETSPHARMA-770x433.jpg", "publishedAt": "2018-09-14T05:52:26Z", "content": "Satish Gupta astrostocktips.in Today\u2019s planetary position: Moon will be transiting in Libra. Jupiter in Taurus. Lord Saturn in Sagittarius. Ketu and Mars in Capricorn. Lord Rahu, Sun and Mercury in Cancer. Venus in Virgo, Pluto in Sagittarius. Neptune in Aqua\u2026 [+2666 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Bajaj Finance, Ceat, Dr Reddy#39;s Labs, Wipro to get astrological support for the week: Satish Gupta", "description": "Pharma stocks like Divis Labs, Stride Pharma, Lupin, Ajanta Pharma and Dr Reddy\u00e2\u0080\u0099s Labs will get astrological support for the week, says Satish Gupta of astrostocktips.", "url": "https://www.moneycontrol.com/news/business/markets/bajaj-finance-ceat-dr-reddys-labs-wipro-to-get-astrological-support-for-the-week-satish-gupta-2934591.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/01/Nifty_Budget_2017_sensex_BSe_up1-770x433.jpg", "publishedAt": "2018-09-10T05:56:34Z", "content": "Satish Gupta astrostocktips.in Weekly planetary position: During the week, Moon will be transiting in Virgo and Libra. Lord Saturn in Sagittarius. Venus and Lord Jupiter in Libra. Lord Ketu and Mars in Capricorn. Lord Rahu in Cancer. Sun and Mercury in Leo. P\u2026 [+2890 chars]"}, {"source": {"id": null, "name": "Indianexpress.com"}, "author": "PTI", "title": "Rupee edges higher by 4 paise against US dollar; Sensex, Nifty retract in early trade", "description": "The BSE benchmark Sensex drifted lower by nearly 166 points and the NSE Nifty slipped below the 11,500-level in the opening session Friday due to intense selling mainly in banking, power and healthcare shares amid weak Asian cues.", "url": "https://indianexpress.com/article/business/market/rupee-value-us-dollar-sensex-nifty-5344370/", "urlToImage": "https://images.indianexpress.com/2018/05/rupee-money-currency-759.jpg?w=759", "publishedAt": "2018-09-07T05:34:20Z", "content": "By: PTI | Mumbai | Published: September 7, 2018 11:04:20 am The rupee Thursday plunged to new record low of 72.11 a dollar in intra-day trade before closing at 71.99, showing a steep 24 paise fall. The rupee Friday opened on a positive note and was trading ma\u2026 [+1996 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "D-Street Buzz: Metal stocks shine with Hindalco up 2%; GSK Consumer leads FMCG rally", "description": "The breadth of the market favoured declines, with 656 stocks advancing, 1056 declining and 353 remaining unchanged. On BSE, 1058 stocks advanced, 1500 declined and 166 remained unchanged.", "url": "https://www.moneycontrol.com/news/business/markets/d-street-buzz-metal-stocks-shines-with-hindalco-up-2-gsk-consumer-leads-fmcg-rally-2945531.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2017/08/sensex_NSE_BSE_Stocks_Stock_market_bse1-770x433.jpg", "publishedAt": "2018-09-12T09:03:34Z", "content": "Wednesday afternoon is seeing some bounce back in the Indian stock market with the Nifty50 up 75 points and is trading at 11,363 while the Sensex is trading higher by 250 points at 37,663. At 14:20 hrs, Nifty FMCG is the outperforming sector, up over 2 percen\u2026 [+1588 chars]"}]}